Element Science

Element Science

Develops wearable defibrillator for cardiac arrest

About Element Science

Simplify's Rating
Why Element Science is rated
B-
Rated D+ on Competitive Edge
Rated B on Growth Potential
Rated A on Rating Differentiation

Industries

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Series C

Total Funding

$183.1M

Headquarters

San Francisco, California

Founded

2013

Overview

Element Science focuses on developing health technology aimed at preventing sudden cardiac arrest. Its main product, Jewel®, is a wearable defibrillator that offers continuous protection for users at risk of cardiac events. Although Jewel® is not yet available for sale in the U.S., it represents a significant advancement in medical devices. The company targets individuals who are at risk, which includes millions globally, and plans to generate revenue through the sale of these devices to consumers, healthcare providers, and insurance companies. Element Science distinguishes itself from competitors by prioritizing diversity, equity, inclusion, and belonging within its workforce, reflecting its commitment to positive societal impact. Additionally, the company is in a growth phase, actively expanding its team to enhance its market presence and revenue potential.

📈
Significant Headcount Growth
Simplify Jobs

Simplify's Take

What believers are saying

  • Jewel® device aligns with growing demand for remote patient monitoring solutions.
  • Global wearable medical device market projected to reach USD 196.5 billion by 2030.
  • FDA's expedited approval process could accelerate Jewel® device's market entry.

What critics are saying

  • Increasing competition from companies like iRhythm Technologies and BioTelemetry.
  • Regulatory hurdles in the U.S. could delay Jewel® device's commercial availability.
  • Cybersecurity threats could compromise data integrity and patient safety of Jewel® device.

What makes Element Science unique

  • Element Science's Jewel® device integrates machine learning for predictive healthcare solutions.
  • The Jewel® device offers 24/7 protection against sudden cardiac arrest, unlike traditional devices.
  • Element Science emphasizes DEIB, enhancing its workplace culture and innovation potential.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$183.1M

Above

Industry Average

Funded Over

3 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Above Average

Industry standards

$50M
$50M
Medium
$62M
SeatGeek
$100M
Oura
$145.6M
Element Science

Benefits

Stock Options

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Retirement Plan

Unlimited Paid Time Off

Paid Vacation

Paid Holidays

FSA (Flexible Spending Accounts)

HSA (Health Savings Account)

Employee Assistance Program through PEO

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

5%

2 year growth

11%
Valdosta Daily Times
Jul 8th, 2024
Element Science Receives Prestigious International Red Dot Design Award for Innovative Jewel(R) Patch Wearable Cardioverter Defibrillator

Element Science, an innovative health technology company pioneering a digital wearable platform that monitors and protects high-risk cardiovascular patients, announces that its Jewel(R) Wearable Patch Cardioverter Defibrillator (Jewel) has received the prestigious Red Dot Design Award.

Business Wire
May 15th, 2024
Element Science Appoints Lee Smith, Jr. As The Company'S First Head Of Commercial

With nearly 20 years of successful leadership experience in sales strategy, commercial operations, and customer success, Mr. Smith will be instrumental in driving the launch and expansion of Element Science's Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) in globally markets. (Photo: Business Wire)With nearly 20 years of successful leadership experience in sales strategy, commercial operations, and customer success, Mr. Smith will be instrumental in driving the launch and expansion of Element Science's Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) in globally markets. (Photo: Business Wire)SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company developing a pioneering digital wearable platform for high-risk cardiovascular patients, announced the appointment of Lee Smith Jr. as the company's first Head of Commercial

Business Wire
Jan 25th, 2024
Element Science Receives Ce Mark Ukca Mark For The Jewel® Patch-Wearable Cardioverter Defibrillator

Element Science Receives CE Mark & UKCA Mark for the Jewel® Patch-Wearable Cardioverter Defibrillator First of its kind life-saving technology receives CE Mark and UKCA Mark, paving the way for enhanced protection of patients with elevated risk of sudden cardiac arrest. (Photo: Business Wire)Element Science Receives CE Mark & UKCA Mark for the Jewel® Patch-Wearable Cardioverter Defibrillator First of its kind life-saving technology receives CE Mark and UKCA Mark, paving the way for enhanced protection of patients with elevated risk of sudden cardiac arrest. (Photo: Business Wire)SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, announced that it has received the European Union’s CE mark certification and Great Britain’s UK Conformity Assessed (UKCA) marking for its novel Patch Wearable Cardioverter Defibrillator (P-WCD) from its Notified Body, the BSI Group.The Jewel P-WCD was designed to address limitations with traditional garment-based WCDs. While these garment-based WCDs have demonstrated the ability to treat sudden cardiac arrest (SCA), a leading cause of death in the United States and in Europe, challenges related to patient comfort and compliance have resulted in avoidable deaths and limited their widespread adoption.The effectiveness of the Jewel defibrillator was confirmed in the Jewel EP Lab Study, conducted in Prague, Czech Republic, in which 16 patients experiencing ventricular arrhythmias were successfully converted to a normal heart rhythm after a single therapeutic shock. The Jewel IDE Study, a pivotal study of 305 patients presented at the American Heart Association’s 2023 Annual Scientific Sessions demonstrated significant patient compliance and protected time resulting in a high number of successful patient saves and no deaths or serious adverse events related to the device (www.ElementScience.com/ide-study/ ).Dr. Uday N

Business Wire
Oct 26th, 2022
Element Science Appoints Trish Howell As Chief Operating Officer | Business Wire

SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced that Trish Howell has been appointed as the Company’s new Chief Operating Officer, effective October 17, 2022. “ Ms. Howell is a transformational leader who has excelled in her positions prior to joining Element Science. As an innovative and seasoned executive, she expands the capabilities of our leadership team at an inflection point of our growth. Her experience in building successful commercial operations at medical device companies gives her a critically valuable perspective that will be an indispensable asset as we look forward to commercializing our technology and expanding our pipeline of products,” said Uday N. Kumar, MD, Founder, President and CEO

Business Wire
Oct 26th, 2022
Element Science Appoints Trish Howell As Chief Operating Officer

SAN FRANCISCO--(BUSINESS WIRE)--Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients transitioning from hospital to home, announced that Trish Howell has been appointed as the Company’s new Chief Operating Officer, effective October 17, 2022. “ Ms. Howell is a transformational leader who has excelled in her positions prior to joining Element Science. As an innovative and seasoned executive, she expands the capabilities of our leadership team at an inflection point of our growth. Her experience in building successful commercial operations at medical device companies gives her a critically valuable perspective that will be an indispensable asset as we look forward to commercializing our technology and expanding our pipeline of products,” said Uday N. Kumar, MD, Founder, President and CEO

Recently Posted Jobs

Sign up to get curated job recommendations

Purchasing Manager

$140k - $150k/yr

San Carlos, CA, USA

Accounting Manager

$135k - $145k/yr

San Francisco, CA, USA

Director – IT Enterprise Applications

$200k - $220k/yr

San Francisco, CA, USA

See All Jobs

Element Science is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Element Science's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to Element Science

Cardiosense

Cardiosense

Chicago, Illinois

Sibel Health

Sibel Health

Evanston, Illinois

Eko

Eko

Oakland, California

Accounting Manager

$135k - $145k/yr

San Francisco, CA, USA

Director – IT Enterprise Applications

$200k - $220k/yr

San Francisco, CA, USA

See All Jobs

Element Science is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Element Science's jobs every few hours, so check again soon! Browse all jobs →

People Also Viewed

Discover companies similar to Element Science

Cardiosense

Cardiosense

Chicago, Illinois

Sibel Health

Sibel Health

Evanston, Illinois

Eko

Eko

Oakland, California